Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Martínez-Beltrán J[au]:

Validation of the FRAIL scale in Mexican elderly: results from the Mexican Health and Aging Study. Díaz de León González E et al. Aging Clin Exp Res. (2016)

A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. Baquero F et al. J Antimicrob Chemother. (1991)

Temocillin. In vitro activity compared with other antibiotics. Martinez-Beltran J et al. Drugs. (1985)

Search results

Items: 49

1.

Validation of the FRAIL scale in Mexican elderly: results from the Mexican Health and Aging Study.

Díaz de León González E, Gutiérrez Hermosillo H, Martinez Beltran JA, Chavez JH, Palacios Corona R, Salinas Garza DP, Rodriguez Quintanilla KA.

Aging Clin Exp Res. 2016 Oct;28(5):901-8. doi: 10.1007/s40520-015-0497-y. Epub 2015 Dec 8.

2.

Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil.

Alvarez-Sala JL, Kardos P, Martínez-Beltrán J, Coronel P, Aguilar L.

Antimicrob Agents Chemother. 2006 May;50(5):1762-7.

3.

Cloning and functional analysis of the gene encoding the 33- to 36-kilodalton outer membrane protein associated with carbapenem resistance in Acinetobacter baumannii.

del Mar Tomás M, Beceiro A, Pérez A, Velasco D, Moure R, Villanueva R, Martínez-Beltrán J, Bou G.

Antimicrob Agents Chemother. 2005 Dec;49(12):5172-5.

4.

[Evaluation of an advisory program in antibiotic therapy].

Cobo Reinoso J, Oliva Domínguez J, Soler Vigil M, Martínez-Beltrán J, Pedraza Cezón L, Moreno Guillén S.

Rev Clin Esp. 2002 Feb;202(2):78-83. Spanish.

PMID:
11996759
5.

Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin.

Fortún J, Navas E, Martínez-Beltrán J, Pérez-Molina J, Martín-Dávila P, Guerrero A, Moreno S.

Clin Infect Dis. 2001 Jul 1;33(1):120-5. Epub 2001 Jun 5.

PMID:
11389505
6.
8.

Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated beta-lactamase from an Escherichia coli strain isolated in Spain.

Bou G, Oliver A, Ojeda M, Monzón C, Martínez-Beltrán J.

Antimicrob Agents Chemother. 2000 Sep;44(9):2549-53.

9.

OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain.

Bou G, Oliver A, Martínez-Beltrán J.

Antimicrob Agents Chemother. 2000 Jun;44(6):1556-61. Erratum in: Antimicrob Agents Chemother. 2006 Jun;50(6):2280.

10.
11.

Biochemical and genetic characteristics of TEM-29B, a novel extended spectrum beta-lactamase.

Bou G, Martínez-Beltrán J, Cerveró G, Pérez-Díaz JC.

FEMS Microbiol Lett. 1999 May 1;174(1):185-90.

12.

Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients.

Casado JL, Valdezate S, Calderon C, Navas E, Frutos B, Guerrero A, Martinez-Beltran J.

J Infect Dis. 1999 Jun;179(6):1553-6.

PMID:
10228081
13.

Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain.

Vila J, Ruiz J, Navia M, Becerril B, Garcia I, Perea S, Lopez-Hernandez I, Alamo I, Ballester F, Planes AM, Martinez-Beltran J, de Anta TJ.

J Clin Microbiol. 1999 Mar;37(3):758-61.

14.

[Criteria of the MENSURA group for the definition of the critical points of sensitivity to antibiotics].

Baquero F, Martínez-Beltrán J, Cantón R.

Enferm Infecc Microbiol Clin. 1998 Feb;16(2):85-92. Review. Spanish. No abstract available.

PMID:
9586367
15.

[in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].

Martínez-Beltrán J, Calderón C, Sierra MP, Alvarez M, Cantón R.

Enferm Infecc Microbiol Clin. 1997 Sep;15 Suppl 1:20-6. Spanish.

PMID:
9410065
16.

Beta-lactam stability in frozen microdilution PASCO MIC panels using strains with known resistance mechanisms as biosensors.

Valdezate S, Martínez-Beltrán J, de Rafael L, Baquero F, Cantón R.

Diagn Microbiol Infect Dis. 1996 Oct;26(2):53-61.

PMID:
8985656
17.

Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.

Martínez-Beltrán J, Cantón R, Liñares J, García de Lomas J, Gimeno C, Tubau F, Baquero F.

Eur J Clin Microbiol Infect Dis. 1995 Mar;14(3):244-52.

PMID:
7614970
18.

Right-sided endocarditis caused by Staphylococcus aureus in drug abusers.

Fortún J, Pérez-Molina JA, Añón MT, Martínez-Beltrán J, Loza E, Guerrero A.

Antimicrob Agents Chemother. 1995 Feb;39(2):525-8.

19.

New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak.

Morosini MI, Canton R, Martinez-Beltran J, Negri MC, Perez-Diaz JC, Baquero F, Blazquez J.

Antimicrob Agents Chemother. 1995 Feb;39(2):458-61.

20.

Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants.

Gonzalez Leiza M, Perez-Diaz JC, Ayala J, Casellas JM, Martinez-Beltran J, Bush K, Baquero F.

Antimicrob Agents Chemother. 1994 Sep;38(9):2150-7.

21.

Native-valve endocarditis due to Neisseria sicca.

López-Vélez R, Fortun J, de Pablo C, Martínez Beltran J.

Clin Infect Dis. 1994 Apr;18(4):660-1. No abstract available.

PMID:
8038335
22.

Development of an enzyme-linked immunosorbent assay method for typing and quantitation of Klebsiella pneumoniae lipopolysaccharide: application to serotype O1.

Albertí S, Hernández-Allés S, Gil J, Reina J, Martínez-Beltrán J, Camprubí S, Tomás JM, Benedí VJ.

J Clin Microbiol. 1993 May;31(5):1379-81.

23.

Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases.

Fernandez-Rodriguez A, Canton R, Perez-Diaz JC, Martinez-Beltran J, Picazo JJ, Baquero F.

Antimicrob Agents Chemother. 1992 Nov;36(11):2536-8.

24.

[Staphylococcus aureus: mechanisms of methicillin resistance].

Martínez-Beltrán J, Cantón R.

Enferm Infecc Microbiol Clin. 1992 Nov;10 Suppl 3:7-15. Review. Spanish. No abstract available.

PMID:
1477136
25.

Comparative in vitro activity of clarithromycin. Spanish Collaborative Group.

Loza E, Martínez Beltrán J, Baquero F, León A, Cantón R, Garijo B.

Eur J Clin Microbiol Infect Dis. 1992 Sep;11(9):856-66.

PMID:
1468430
26.

The E-Test as an epidemiologic tool.

Baquero F, Cantón R, Martinez-Beltrán J, Bolmström A.

Diagn Microbiol Infect Dis. 1992 Jul;15(5):483-7.

PMID:
1643830
27.

In vitro activity of azithromycin and tetracycline against 358 clinical isolates of Brucella melitensis.

Landínez R, Liñares J, Loza E, Martínez-Beltrán J, Martín R, Baquero F.

Eur J Clin Microbiol Infect Dis. 1992 Mar;11(3):265-7.

PMID:
1317801
28.

A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe.

Baquero F, Martínez-Beltrán J, Loza E.

J Antimicrob Chemother. 1991 Dec;28 Suppl C:31-8. Review.

PMID:
1787127
29.

The incidence and beta-lactam resistance of Proteus vulgaris in hospital infections: the last decade.

Gomez-Alferez A, Baquero F, Canton R, Loza E, Martinez-Beltran J.

J Chemother. 1991 Oct;3(5):283-8.

PMID:
1809807
30.

[Imipenem-cilastatin cure of meningitis caused by Acinetobacter calcoaceticus].

Sánchez JF, Sanz-Hospital J, Guerrero A, Martínez-Beltrán J, Quereda C.

Enferm Infecc Microbiol Clin. 1991 Oct;9(8):512-3. Review. Spanish. No abstract available.

PMID:
1805958
31.

Staphylococci in Spain.

Bouza E, Martínez Beltran J; Spanish Group for the Study of Staphylococci.

J Chemother. 1989 Jul;1(4 Suppl):15-7. No abstract available.

PMID:
16312285
32.

[Evaluation of the treatment with oral ciprofloxacin: experience with 24 patients].

Parras F, Torroba L, Buzón L, Martínez-Beltrán J, Loza E, Baquero F.

Enferm Infecc Microbiol Clin. 1989 May;7(5):261-5. Spanish.

PMID:
2490722
33.

Septic arthritis by Salmonella enteritidis after heart transplantation.

Martin-Santos JM, Alonso-Pulpon L, Pradas G, Cuervas-Mons V, Anguita M, Mulero-Mendoza J, Escribano E, Martinez-Beltran J, Figuera-Aymerich D.

J Heart Transplant. 1987 May-Jun;6(3):177-9.

PMID:
3309221
34.

Cure of a case of Haemophilus aphrophilus endocarditis with a combination of fosfomycin and gentamicin.

Moreno S, Ezpeleta C, Parras F, Barros C, Martinez Beltrán J, Buzón L.

J Antimicrob Chemother. 1986 Dec;18(6):771-2. No abstract available.

PMID:
3818500
35.

Evaluation of aztreonam in the treatment of severe bacterial infections.

Romero-Vivas J, Rodríguez-Créixems M, Bouza E, Hellín T, Guerrero A, Martínez-Beltrán J, García de la Torre M.

Antimicrob Agents Chemother. 1985 Aug;28(2):222-6.

36.

[Infectious endocarditis. 5 years' experience].

Romero-Vivas J, Romero-Vivas F, Bouza E, Martínez-Beltrán J, Rodríguez-Créixems M, Franco C, Marín E, Fernández-Espino R.

Med Clin (Barc). 1985 Apr 30;84(16):637-42. Spanish. No abstract available.

PMID:
4033238
37.

Klebsiella bacteremia: an analysis of 100 episodes.

García de la Torre M, Romero-Vivas J, Martínez-Beltrán J, Guerrero A, Meseguer M, Bouza E.

Rev Infect Dis. 1985 Mar-Apr;7(2):143-50. Review.

PMID:
3890094
38.

Temocillin. In vitro activity compared with other antibiotics.

Martinez-Beltran J, Loza E, Gomez-Alferez A, Romero-Vivas J, Bouza E.

Drugs. 1985;29 Suppl 5:91-7.

PMID:
3875477
39.

Brucellosis and parenteral drug abuse.

Romero-Vivas J, Guerrero A, Buzon LM, Berenguer J, Martinez-Beltran J, Bouza E.

Eur J Clin Microbiol. 1984 Aug;3(4):319-20. No abstract available.

PMID:
6386462
40.

[Pseudomonas aeruginosa pneumonia acquired outside the hospital in a non-immunodepressed patient].

Erice A, Romero-Vivas J, Martínez-Beltrán J, Guerrero A, Bouza E.

Med Clin (Barc). 1983 Dec 3;81(18):811-2. Spanish. No abstract available.

PMID:
6418996
41.

Comparison of ceftazidime concentrations in bile and serum.

Bouza E, Hellín T, Rodríguez-Creixems M, Martínez-Beltrán J, Loza E, Baquero F.

Antimicrob Agents Chemother. 1983 Jul;24(1):104-6.

42.

Evaluation of ceftazidime in the treatment of severe bacterial infection.

Bouza E, Hellín T, Sanz-Hospital J, Rodríguez-Creixems M, Loza E, Martínez-Beltrán J.

J Antimicrob Chemother. 1983 Jul;12 Suppl A:153-9.

PMID:
6352616
43.

Evaluation of lamoxactam in the treatment of severe bacterial infections.

Bouza E, Martínez-Beltrán J, Rodríguez-Creixems M, Loza E, Pérez del Rio J, Guerrero A, Hospital JS.

Chemotherapy. 1983;29(5):373-83.

PMID:
6617297
44.

Comparative effects of moxalactam and gentamicin on human polymorphonuclear leukocyte functions.

Burgaleta C, Martínez-Beltrán J, Bouza E.

Antimicrob Agents Chemother. 1982 May;21(5):718-20.

45.

[Intraventricular amikacin in the treatment of meningoventriculitis caused by Gram-negative organisms].

Ludeña Carpio C, Madero López L, Barrio Corrales F, Lozano Jiménez C, Martínez Beltrán J, Loza E.

An Esp Pediatr. 1981 Nov;15(5):503-6. Spanish. No abstract available.

PMID:
7036809
46.

Yersinia enterocolitica Septicemia.

Bouza E, Dominguez A, Meseguer M, Buzon L, Boixeda D, Revillo MJ, de Rafael L, Martinez-Beltran J.

Am J Clin Pathol. 1980 Oct;74(4):404-9.

PMID:
7424822
48.

Preliminary clinical trial with amikacin in chronic recurrent gram-negative bacterial infections refractory to other antimicrobial agents.

Dámaso D, Moreno-López M, Martínez-Beltrán J, García-Iglesias MC.

J Infect Dis. 1976 Nov;134 SUPPL:S381-3.

PMID:
993631
49.

Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.

Dámaso D, Moreno-López M, Martínez-Beltrán J, García-Iglesias MC.

J Infect Dis. 1976 Nov;134 SUPPL:S394-90.

PMID:
825591

Supplemental Content

Loading ...
Support Center